The
cryopreservation of cells underpins many areas of biotechnology,
healthcare, and fundamental science by enabling the banking and distribution
of cells. Cryoprotectants are essential to prevent cold-induced damage.
Here, we demonstrate that extracellular localization of antifreeze
proteins can significantly enhance post-thaw recovery of mammalian
cell monolayers cryopreserved using dimethyl sulfoxide, whereas they
show less benefit in suspension cryopreservation. A type III antifreeze
protein (AFPIII) was used as the macromolecular ice recrystallization
inhibitor and its intra/extracellular locations were controlled by
using Pep-1, a cell-penetrating peptide. Flow cytometry and confocal
microscopy confirmed successful delivery of AFPIII. The presence of
extracellular AFPIII dramatically increased post-thaw recovery in
a challenging 2-D cell monolayer system using just 0.8 mg·mL–1, from 25% to over 60%, whereas intracellularly delivered
AFPIII showed less benefit. Interestingly, the antifreeze protein
was less effective when used in suspension cryopreservation of the
same cells, suggesting that the cryopreservation format is also crucial.
These observations show that, in the discovery of macromolecular cryoprotectants,
intracellular delivery of ice recrystallization inhibitors may not
be a significant requirement under “slow freezing” conditions,
which will help guide the design of new biomaterials, in particular,
for cell storage.